Ovarian Cancer in Iran: National Based Study
Ovarian cancer (OC) is the 7 most common cancer, with 239,000 new cases per year. In Iran, it is the 8 most common cancer, with an ASIR of 3.9/100,000 women. The 5-year overall survival in Iran based on previous studies is about 61% which in comparison with eastern countries has better survival. The...
Gespeichert in:
| Veröffentlicht in: | Iranian journal of public health 2023-04, Vol.52 (4), p.797-808 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 808 |
|---|---|
| container_issue | 4 |
| container_start_page | 797 |
| container_title | Iranian journal of public health |
| container_volume | 52 |
| creator | Akbari, Atieh Azizmohammad Looha, Mehdi Moradi, Afshin Akbari, Mohammad Esmaeil |
| description | Ovarian cancer (OC) is the 7
most common cancer, with 239,000 new cases per year. In Iran, it is the 8
most common cancer, with an ASIR of 3.9/100,000 women. The 5-year overall survival in Iran based on previous studies is about 61% which in comparison with eastern countries has better survival.
The study included patients from the Iran National Cancer Registry from 2009-2014. Several steps were taken to control data quality. This study used a Kaplan-Meier survival curve to compare OC survival rates across geographical, pathological, and other variables. All analyses were done in R (4.02) and SPSS (26), with a 0.05
-value considered statistically significant.
The study enrolled 7977 cases of OC. OC's ASIR was 4.10/100,000. In epithelial and non-specific OC, ASIR was >0.5. Five-year survival was 55% and 10-year survival was 45%.
OC is the 8
most common cancer in Iran, with lower age-specific incidence and better overall survival than East Asia and North America. In Iran, as in Eastern Europe, OC incidence correlated with reduced total fertility rate and population aging. Five and 10-year overall survival rates were 55% and 44%, respectively, higher than the West. This may be because late stage OC patients are excluded from pathology and classified as "undiagnosed" in death certificates or hospitalization files. |
| doi_str_mv | 10.18502/ijph.v52i4.12453 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10404329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2847750825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-98c8a89ffa2243395dc52951dd0689292f5905fe98434ddb38b7f9fa91c139b43</originalsourceid><addsrcrecordid>eNpdkU1PAjEQhhujEUR_gBeziRcPLvaTtl6MEr8SIgf13JRtKyVLF9tdEv69KyBRTzPJPPNm3nkBOEWwjwSD-MrPFtP-kmFP-whTRvZAF2OG8gGUZH_XC9YBRynNIKQDzPgh6BDOGEJCdMHleKmj1yEb6lDYmPmQPUcdrrMXXfsq6DK708ma7LVuzOoYHDhdJnuyrT3w_nD_NnzKR-PH5-HtKC8oFnUuRSG0kM5pjCkhkpmCYcmQMXAgJJbYMQmZs1JQQo2ZEDHhTjotUYGInFDSAzcb3UUzmVtT2FBHXapF9HMdV6rSXv2dBD9VH9VSIUghJVi2ChdbhVh9NjbVau5TYctSB1s1SWFBOWdQYNai5__QWdXE1nlLcSk55RsKbagiVilF63bXIKjWYajvMNQ6DLUOo905-21jt_HzffIFygSEsw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2799747825</pqid></control><display><type>article</type><title>Ovarian Cancer in Iran: National Based Study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Akbari, Atieh ; Azizmohammad Looha, Mehdi ; Moradi, Afshin ; Akbari, Mohammad Esmaeil</creator><creatorcontrib>Akbari, Atieh ; Azizmohammad Looha, Mehdi ; Moradi, Afshin ; Akbari, Mohammad Esmaeil</creatorcontrib><description>Ovarian cancer (OC) is the 7
most common cancer, with 239,000 new cases per year. In Iran, it is the 8
most common cancer, with an ASIR of 3.9/100,000 women. The 5-year overall survival in Iran based on previous studies is about 61% which in comparison with eastern countries has better survival.
The study included patients from the Iran National Cancer Registry from 2009-2014. Several steps were taken to control data quality. This study used a Kaplan-Meier survival curve to compare OC survival rates across geographical, pathological, and other variables. All analyses were done in R (4.02) and SPSS (26), with a 0.05
-value considered statistically significant.
The study enrolled 7977 cases of OC. OC's ASIR was 4.10/100,000. In epithelial and non-specific OC, ASIR was >0.5. Five-year survival was 55% and 10-year survival was 45%.
OC is the 8
most common cancer in Iran, with lower age-specific incidence and better overall survival than East Asia and North America. In Iran, as in Eastern Europe, OC incidence correlated with reduced total fertility rate and population aging. Five and 10-year overall survival rates were 55% and 44%, respectively, higher than the West. This may be because late stage OC patients are excluded from pathology and classified as "undiagnosed" in death certificates or hospitalization files.</description><identifier>ISSN: 2251-6085</identifier><identifier>EISSN: 2251-6093</identifier><identifier>DOI: 10.18502/ijph.v52i4.12453</identifier><identifier>PMID: 37551188</identifier><language>eng</language><publisher>Iran: Tehran University of Medical Sciences</publisher><subject>Cancer ; Control data (computers) ; Fertility ; Original ; Ovarian cancer ; Statistical analysis ; Survival</subject><ispartof>Iranian journal of public health, 2023-04, Vol.52 (4), p.797-808</ispartof><rights>Copyright © 2023 Akbari et al. Published by Tehran University of Medical Sciences.</rights><rights>2023. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023 Akbari et al. Published by Tehran University of Medical Sciences. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-98c8a89ffa2243395dc52951dd0689292f5905fe98434ddb38b7f9fa91c139b43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404329/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404329/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37551188$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akbari, Atieh</creatorcontrib><creatorcontrib>Azizmohammad Looha, Mehdi</creatorcontrib><creatorcontrib>Moradi, Afshin</creatorcontrib><creatorcontrib>Akbari, Mohammad Esmaeil</creatorcontrib><title>Ovarian Cancer in Iran: National Based Study</title><title>Iranian journal of public health</title><addtitle>Iran J Public Health</addtitle><description>Ovarian cancer (OC) is the 7
most common cancer, with 239,000 new cases per year. In Iran, it is the 8
most common cancer, with an ASIR of 3.9/100,000 women. The 5-year overall survival in Iran based on previous studies is about 61% which in comparison with eastern countries has better survival.
The study included patients from the Iran National Cancer Registry from 2009-2014. Several steps were taken to control data quality. This study used a Kaplan-Meier survival curve to compare OC survival rates across geographical, pathological, and other variables. All analyses were done in R (4.02) and SPSS (26), with a 0.05
-value considered statistically significant.
The study enrolled 7977 cases of OC. OC's ASIR was 4.10/100,000. In epithelial and non-specific OC, ASIR was >0.5. Five-year survival was 55% and 10-year survival was 45%.
OC is the 8
most common cancer in Iran, with lower age-specific incidence and better overall survival than East Asia and North America. In Iran, as in Eastern Europe, OC incidence correlated with reduced total fertility rate and population aging. Five and 10-year overall survival rates were 55% and 44%, respectively, higher than the West. This may be because late stage OC patients are excluded from pathology and classified as "undiagnosed" in death certificates or hospitalization files.</description><subject>Cancer</subject><subject>Control data (computers)</subject><subject>Fertility</subject><subject>Original</subject><subject>Ovarian cancer</subject><subject>Statistical analysis</subject><subject>Survival</subject><issn>2251-6085</issn><issn>2251-6093</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkU1PAjEQhhujEUR_gBeziRcPLvaTtl6MEr8SIgf13JRtKyVLF9tdEv69KyBRTzPJPPNm3nkBOEWwjwSD-MrPFtP-kmFP-whTRvZAF2OG8gGUZH_XC9YBRynNIKQDzPgh6BDOGEJCdMHleKmj1yEb6lDYmPmQPUcdrrMXXfsq6DK708ma7LVuzOoYHDhdJnuyrT3w_nD_NnzKR-PH5-HtKC8oFnUuRSG0kM5pjCkhkpmCYcmQMXAgJJbYMQmZs1JQQo2ZEDHhTjotUYGInFDSAzcb3UUzmVtT2FBHXapF9HMdV6rSXv2dBD9VH9VSIUghJVi2ChdbhVh9NjbVau5TYctSB1s1SWFBOWdQYNai5__QWdXE1nlLcSk55RsKbagiVilF63bXIKjWYajvMNQ6DLUOo905-21jt_HzffIFygSEsw</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Akbari, Atieh</creator><creator>Azizmohammad Looha, Mehdi</creator><creator>Moradi, Afshin</creator><creator>Akbari, Mohammad Esmaeil</creator><general>Tehran University of Medical Sciences</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>PATMY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230401</creationdate><title>Ovarian Cancer in Iran: National Based Study</title><author>Akbari, Atieh ; Azizmohammad Looha, Mehdi ; Moradi, Afshin ; Akbari, Mohammad Esmaeil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-98c8a89ffa2243395dc52951dd0689292f5905fe98434ddb38b7f9fa91c139b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cancer</topic><topic>Control data (computers)</topic><topic>Fertility</topic><topic>Original</topic><topic>Ovarian cancer</topic><topic>Statistical analysis</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akbari, Atieh</creatorcontrib><creatorcontrib>Azizmohammad Looha, Mehdi</creatorcontrib><creatorcontrib>Moradi, Afshin</creatorcontrib><creatorcontrib>Akbari, Mohammad Esmaeil</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Environmental Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Iranian journal of public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akbari, Atieh</au><au>Azizmohammad Looha, Mehdi</au><au>Moradi, Afshin</au><au>Akbari, Mohammad Esmaeil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ovarian Cancer in Iran: National Based Study</atitle><jtitle>Iranian journal of public health</jtitle><addtitle>Iran J Public Health</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>52</volume><issue>4</issue><spage>797</spage><epage>808</epage><pages>797-808</pages><issn>2251-6085</issn><eissn>2251-6093</eissn><abstract>Ovarian cancer (OC) is the 7
most common cancer, with 239,000 new cases per year. In Iran, it is the 8
most common cancer, with an ASIR of 3.9/100,000 women. The 5-year overall survival in Iran based on previous studies is about 61% which in comparison with eastern countries has better survival.
The study included patients from the Iran National Cancer Registry from 2009-2014. Several steps were taken to control data quality. This study used a Kaplan-Meier survival curve to compare OC survival rates across geographical, pathological, and other variables. All analyses were done in R (4.02) and SPSS (26), with a 0.05
-value considered statistically significant.
The study enrolled 7977 cases of OC. OC's ASIR was 4.10/100,000. In epithelial and non-specific OC, ASIR was >0.5. Five-year survival was 55% and 10-year survival was 45%.
OC is the 8
most common cancer in Iran, with lower age-specific incidence and better overall survival than East Asia and North America. In Iran, as in Eastern Europe, OC incidence correlated with reduced total fertility rate and population aging. Five and 10-year overall survival rates were 55% and 44%, respectively, higher than the West. This may be because late stage OC patients are excluded from pathology and classified as "undiagnosed" in death certificates or hospitalization files.</abstract><cop>Iran</cop><pub>Tehran University of Medical Sciences</pub><pmid>37551188</pmid><doi>10.18502/ijph.v52i4.12453</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2251-6085 |
| ispartof | Iranian journal of public health, 2023-04, Vol.52 (4), p.797-808 |
| issn | 2251-6085 2251-6093 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10404329 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central; Alma/SFX Local Collection |
| subjects | Cancer Control data (computers) Fertility Original Ovarian cancer Statistical analysis Survival |
| title | Ovarian Cancer in Iran: National Based Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A27%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ovarian%20Cancer%20in%20Iran:%20National%20Based%20Study&rft.jtitle=Iranian%20journal%20of%20public%20health&rft.au=Akbari,%20Atieh&rft.date=2023-04-01&rft.volume=52&rft.issue=4&rft.spage=797&rft.epage=808&rft.pages=797-808&rft.issn=2251-6085&rft.eissn=2251-6093&rft_id=info:doi/10.18502/ijph.v52i4.12453&rft_dat=%3Cproquest_pubme%3E2847750825%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2799747825&rft_id=info:pmid/37551188&rfr_iscdi=true |